Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma

NCT00168727 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Lymphoma, Low-Grade

Interventions

DRUG: ibritumomab tiuxetan (Zevalin®)

Sponsor

Biogen